New Drug Limits Damage and Promotes Regeneration after Stroke

Repurposing an existing anti-inflammatory drug used for Rheumatoid arthritis, Interleukin-1 receptor antagonist (IL-1Ra) has shown promising results for stroke patients. It is proving effective at limiting the initial damage as well as promoting brain repair.  Outcomes after stroke are greatly improved with the hope of restoring function to the brain and regaining motor skills. Click here to learn more